Six members of Congress have announced their support for the Thoroughbred Horseracing Integrity Act of 2015, according to the Coalition for Horse Racing Integrity.
The California Horse Racing Board Oct. 9 said limits on the amount of the trace element cobalt that can be detected in racehorses officially took effect Oct. 5.
Kent Stirling, who has served as executive director of the Florida Horsemen's Benevolent and Protective Association since 1995, will transition out of the position this year.
Keeneland said Oct. 8 it officially is in support of the Thoroughbred Horseracing Integrity Act of 2015 and has joined the Coalition for Horse Racing Integrity, a group that also supports the federal legislation.
The chairman of the International Federation of Horseracing Authorities, in an address Oct. 5 in Paris, France, outlined what he called matters that are critical to the future of racing on an international level.
- By Blood-Horse Staff
- Northeast Region, Midwest Region, Southeast Region, Southwest Region, West Region, Kentucky, Mid-Atlantic Region
ARCI Sept. 29 announced members of a committee that will work with regulators in each racing state to complete implementation of reforms that make up the National Uniform Medication Program.
The New York State Gaming Commission Sept. 24 passed several rule amendments related to equine medication, including further restrictions on the use of non-steroidal anti-inflammatory drugs and a total ban on stanozolol.
California Horse Racing Board commissioner George Krikorian's Big Book has been disqualified from her victory in the July 25 Fleet Treat at Del Mar because of a test that showed elevated levels of acepromazine.
A federally sanctioned medication program is racing's best hope for uniformity. read blog
A Thoroughbred Owners and Breeders Association committee has renewed talks regarding a proposal to phase out use of race-day furosemide in graded stakes.
In a survey designed to combat claims that the leaders of horsemen's groups don't represent their membership, the Florida HBPA Sept. 16 released the results of a poll that said most respondents support use of Lasix.
How would you handicap 'off-Lasix' horses?
The Association of Racing Commissioners International is stepping up efforts to get state regulators to fully adopt the National Uniform Medication Program.
Two research projects designed to study the impact of furosemide on exercise-induced pulmonary hemorrhage will be conducted on behalf of the Grayson-Jockey Club Research Foundation, the organization said Sept. 15.
The United States Anti-Doping Agency says it acted appropriately when allowing Floyd Mayweather to receive an intravenous injection before his May 2 fight with Manny Pacquiao.
The California Horse Racing Board Medication and Track Safety Committee took a step forward Sept. 4 regarding potential employment of third-party furosemide administration in the state.
The people who put their money on the line wagering on horse racing would like to see an overhaul of its drug testing and enforcement, based on results of a recent survey.
The Ohio State Racing Commission is moving forward with what it has called a comprehensive study into the effects of the mineral cobalt on racehorses.
The Indiana Horse Racing Commission said Aug. 31 that none of the 221 samples tested for cobalt during the first 60 days of the Indiana Grand Racing & Casino meet were above the published threshold level.
The New York Thoroughbred Horsemen's Association Sept. 1 said it will commit $450,000 to acquire state-of-the-art equipment for the New York Equine Drug Testing and Research Program at Morrisville State College.
The California Thoroughbred Trainers Aug. 31 said its leadership unanimously agreed to use $150,000 from reserve funds to facilitate race-day camera surveillance in barn areas at California racetracks.
The Louisiana State Racing Commission Aug. 24 adopted the Controlled Therapeutic Medication Schedule of 26 commonly used substances.
A new study funded by the USTA is designed to determine whether the naturally occurring mineral cobalt, when administered in larger, regular doses, has blood-doping qualities and could enhance performance.
The Coalition for Horse Racing Integrity said Aug. 21 California's failure to adopt third-party administration of the race-day drug furosemide shows the pitfalls of state-by-state regulation.
Use of race-day furosemide will be the topic for a daylong forum put together by the New York State Gaming Commission Aug. 25 in Saratoga Springs, N.Y.
A co-sponsor of federal legislation that would authorize oversight of equine medication and drug-testing said Congress could schedule a committee hearing on the bill this fall. Meanwhile, the debate on the bill continues.
The board of directors of the Thoroughbred Owners and Breeders Association Aug. 12 tackled the issue of whether to support the Thoroughbred Horseracing Integrity Act of 2015.
Bettors need to believe in the product
The opening panel Aug. 11 at the Saratoga Institute on Racing, Equine, and Gaming Law conference set the tone for what figures to be a continued industry battle over federal versus state-by-state regulation.
Do horse racing's current medication control programs stand up? read blog
Leroy Gessmann, president of the Iowa Horsemen's Benevolent and Protective Association, was elected president of the National HBPA Aug. 9 when the board of directors met as part of the organization's summer convention.
The Association of Racing Commissioners International the afternoon of Aug. 9 issued a strong response to comments made during The Jockey Club Round Table conference held earlier in the day in Saratoga Springs, N.Y.
State-by-state efforts to bring about uniformity in medication policies and drug testing aren't sufficient to move the Thoroughbred industry forward speakers said Aug. 9 at The Jockey Club Round Table conference.
The National Thoroughbred Racing Association will host a legislative briefing open to industry stakeholders and other interested parties at 2 p.m. PDT, Aug. 21 in the Del Mar Turf Club Director's Room.
Marc Summers, vice president and general counsel for The Jockey Club, has prepared a side-by-side comparison of two federal bills that propose creating a national program for managing medication use in racehorses.
When the National Horsemen's Benevolent and Protective Association meets Aug. 6-9 for its summer convention, equine medication will again be a major issue for the organization.
A recommendation by an attorney for Delaware racing stewards to drop a therapeutic medication overage case against trainer Todd Pletcher could impact the sport's move toward uniform medication rules, Pletcher's attorney said.
The American Association of Equine Practitioners has released a "Prescription for Racing Reform" that includes "a commitment to identifying non-race day treatment alternatives for exercise-induced pulmonary hemorrhage."
The West Virginia Racing Commission voted July 28 to hire a new equine drug-testing laboratory when the contract with its current lab ends at the end of August.
In an unusual development, Canterbury Park has come to the defense of top trainer McLean Robertson, who was suspended for 90 days and fined $2,000 by the Minnesota Racing Commission for a positive test for a Class 1 drug.
Trainer Tom Amoss and the Indiana Horse Racing Commission have entered into a settlement agreement in a complex case involving a medication positive at Hoosier Park Racing & Casino in 2011.
West Virginia has joined other states in the Mid-Atlantic region in posting an advisory regarding use of two therapeutic drugs that can be problematic for horsemen.
Standardbred trainer Bradley Moffitt has been suspended for 10 years for a positive test for darbepoetin alfa, marking the first time a synthetic blood doping agent has been found in Indiana.
According to the California Horse Racing Board, there were only four Class 1, 2, or 3 medication violations in the state during the 2014-2015 fiscal year, the lowest number in at least 40 years.
An effort that began in the Mid-Atlantic region more than two years ago has made "significant progress," according to the Racing Medication and Testing Consortium.
Trainer Juan Vazquez is slowly running out of Mid-Atlantic tracks at which to run his horses after Delaware Park informed the trainer he is no longer welcome to race at the track.
The Kentucky Horse Racing Commission on June 29 delayed taking a vote on proposed rules on medication testing, withdrawal guidelines, and disciplinary measures and penalties that included rules on the mineral cobalt.
With the latest Thoroughbred racing rule changes now in place, West Virginia has now fully adopted the National Uniform Medication Program.
The Humane Society Veterinary Medical Association said June 23 it will join the Coalition for Horse Racing Integrity, a group that supports federal legislation that would authorize oversight of equine medication.
Gulfstream Park in July plans to experiment with at least two 2-year-old races that will be written for horses that don't compete on race-day furosemide, officials said June 11.
Most Popular Stories
- Nyquist Out of Belmont Stakes with Fever
- Nyquist Spikes Fever; Did Not Ship to Belmont
- Derby Runner-Up Commanding Curve Retired
- Friesan Fire Colt Tops Midlantic at $825,000
- Possible NYRA Plan Concerns Saratoga Group
- What is Uncle Mo Worth?
- Preakness TV Rating Grows 6%
- So Far, Seven Pointing for Belmont Park
- Exaggerator, Nyquist Set for Belmont Rematch
- Connections of Uncle Lino, Laoban Regroup